AstraZeneca and Daiichi Sankyo’s Enhertu followed by THP showed an improved safety profile vs. standard of careFirst Phase III trial to demonstrate benefit of Enhertu in early breast cancer Positive ...

Don't ignore those symptoms. Head and neck cancers are far more manageable, and often curable, with less aggressive treatment ...